Keros Therapeutics Inc
NASDAQ:KROS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Keros Therapeutics Inc
NASDAQ:KROS
|
US |
|
Civeo Corp
NYSE:CVEO
|
US |
|
TOMI Environmental Solutions Inc
NASDAQ:TOMZ
|
US |
|
F
|
Feytech Holdings Bhd
KLSE:FEYTECH
|
MY |
|
B
|
Biome Australia Ltd
ASX:BIO
|
AU |
|
X
|
Xplora Technologies AS
OSE:XPLRA
|
NO |
|
P
|
Przedsiebiorstwo Hydrauliki Silowej Hydrotor SA
WSE:HDR
|
PL |
|
Change Inc
TSE:3962
|
JP |
|
Tarena International Inc
NASDAQ:TCTM
|
CN |
|
Hawkins Inc
NASDAQ:HWKN
|
US |
|
K
|
Kri Kri Milk Industry SA
ATHEX:KRI
|
GR |
|
Eurasia Mining PLC
LSE:EUA
|
UK |
|
Luna Innovations Inc
NASDAQ:LUNA
|
US |
|
Miramar Resources Ltd
ASX:M2R
|
AU |
|
Hain Celestial Group Inc
NASDAQ:HAIN
|
US |
|
Deep Medicine Acquisition Corp
NASDAQ:TRUG
|
US |
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
CNO Financial Group Inc
NYSE:CNO
|
US |
|
CMMB Vision Holdings Ltd
HKEX:471
|
HK |
|
D
|
Daiwa Heavy Industry Co Ltd
TSE:5610
|
JP |
|
N
|
Ningbo Shanshan Co Ltd
SSE:600884
|
CN |
|
S
|
Seven West Media Ltd
SWB:WA7
|
AU |
|
Merchants Bancorp
NASDAQ:MBIN
|
US |
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
CA |
Bankruptcy Probability
Keros Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Keros Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Keros Therapeutics Inc
NASDAQ:KROS
|
207.4m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Keros Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Keros Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
